Publicaciones
Esparza‑López J, Longoria O, De La Cruz‑Escobar EN, Garibay‑Díaz JC, León‑Rodríguez E and Ibarra‑Sánchez MJ: Paclitaxel resistance is mediated by NF‑B on mesenchymal primary breast cancer cells. Oncol Lett 23: 50, 2022.
Esparza-López, J., Martinez-Aguilar, J. F., and Ibarra-Sánchez, M. J. (2019) Deriving Primary Cancer Cell Cultures for Personalized Therapy. Rev Invest Clin 71, 369-380
Esparza-Lopez, J., Alvarado-Munoz, J. F., Escobar-Arriaga, E., Ulloa-Aguirre, A., and Ibarra-Sanchez, M. J. (2019) Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-kappaB pathways. BMC Cancer 19, 728
Esparza-Lopez, J., Escobar-Arriaga, E., Soto-Germes, S., and Ibarra-Sanchez, M. J. (2017) Breast Cancer Intra-Tumor Heterogeneity: One Tumor, Different Entities. Rev Invest Clin 69, 66-76
Esparza-Lopez, J., Ramos-Elias, P. A., Castro-Sanchez, A., Rocha-Zavaleta, L., Escobar-Arriaga, E., Zentella-Dehesa, A., Leon-Rodriguez, E., Medina-Franco, H., and Ibarra-Sanchez Mde, J. (2016) Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases. BMC Cancer 16, 740
Esparza-Lopez, J., Medina-Franco, H., Escobar-Arriaga, E., Leon-Rodriguez, E., Zentella-Dehesa, A., and Ibarra-Sanchez, M. J. (2013) Doxorubicin induces atypical NF-kappaB activation through c-Abl kinase activity in breast cancer cells. J Cancer Res Clin Oncol 139, 1625-1635
Publicaciones en colaboración
2022
Saldivar-Cerón, H. I., O. Villamar-Cruz, C. M. Wells, I. Oguz, F. Spaggiari, J. Chernoff, G. Patiño-López, S. Huerta-Yepez, M. Montecillo-Aguado, C. M. Rivera-Pazos, M. A. Loza-Mejía, A. Vivar-Sierra, P. Briseño-Díaz, A. Zentella-Dehesa, A. Leon-Del-Rio, A. López-Saavedra, L. Padierna-Mota, M. d. J. Ibarra-Sánchez, J. Esparza-López, R. Hernández-Rivas and L. E. Arias-Romero (2022). "p21-Activated Kinase 1 Promotes Breast Tumorigenesis via Phosphorylation and Activation of the Calcium/Calmodulin-Dependent Protein Kinase II." Frontiers in Cell and Developmental Biology 9.
2021
Aguilar-Valdes, A., L. G. Noriega, A. R. Tovar, M. J. Ibarra-Sanchez, V. A. Sosa-Hernandez, J. L. Maravillas-Montero and J. Martinez-Aguilar (2021). "SWATH-MS proteomics of PANC-1 and MIA PaCa-2 pancreatic cancer cells allows identification of drug targets alternative to MEK and PI3K inhibition." Biochem Biophys Res Commun 552: 23-29.
2021
Lara-Sotelo, G., L. Díaz, R. García-Becerra, E. Avila, H. Prado-Garcia, G. Morales-Guadarrama, M. d. J. Ibarra-Sánchez, J. Esparza-López, F. Larrea and J. García-Quiroz (2021). "α-Mangostin Synergizes the Antineoplastic Effects of 5-Fluorouracil Allowing a Significant Dose Reduction in Breast Cancer Cells." Processes 9(3): 458.
2020
Navarrete-Bernal, M. G. C., M. G. Cervantes-Badillo, J. F. Martinez-Herrera, C. O. Lara-Torres, R. Gerson-Cwilich, A. Zentella-Dehesa, M. J. Ibarra-Sanchez, J. Esparza-Lopez, J. J. Montesinos, V. A. Cortes-Morales, D. Osorio-Perez, D. A. Villegas-Osorno, E. Reyes-Sanchez, P. Salazar-Sojo, L. F. Tallabs-Utrilla, S. Romero-Cordoba and L. Rocha-Zavaleta (2020). "Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4." Front Oncol 10: 1206.